Evidence map›Paper›PMID 40298454›Full record

Observational studyNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2025

Impact of Low-Dose Computed Tomography Findings on Cigarette Smoking Cessation Among High-Risk Adults Participating in Lung Cancer Screening.

Evangelos Katsampouris, Amyn Bhamani, Fanta Bojang, Jennifer L Dickson, Helen Hall, Carolyn Horst, Priyam Verghese, Andrew Creamer, Ruth Prendecki, Chuen Khaw and 104 more

Abstract readObservational Study
In one paragraph

Observational study in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

114 authors.

Evangelos KatsampourisCentre for Cancer Screening, Prevention, Detection and Early Diagnosis, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.ORCID 0000-0001-5211-6572
Amyn BhamaniLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Fanta BojangUniversity College London Hospitals NHS Foundation Trust, London, UK.
Jennifer L DicksonLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Helen HallLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Carolyn HorstLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Priyam VergheseLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Andrew CreamerLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.ORCID 0000-0002-9314-1210
Ruth PrendeckiLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Chuen KhawLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Sophie TisiLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
John McCabeLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Kylie GyertsonUniversity College London Hospitals NHS Foundation Trust, London, UK.
Anne-Marie HackerCancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
Laura FarrellyCancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
Neal NavaniLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Allan HackshawCancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
SUMMIT Consortium
Sam M JanesLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Samantha L QuaifeCentre for Cancer Screening, Prevention, Detection and Early Diagnosis, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Sam M Janes
Jennifer L Dickson
Carolyn Horst
Sophie Tisi
Helen Hall
Priyam Verghese
Andrew Creamer
Thomas Callender
Ruth Prendecki
Amyn Bhamani
Mamta Ruparel
Allan Hackshaw
Laura Farrelly
Jon Teague
Anne-Marie Mullin
Kitty Chan
Rachael Sarpong
Malavika Suresh
Samantha L Quaife
Arjun Nair
Anand Devaraj
Kylie Gyertson
Vicky Bowyer
Ethaar El-Emir
Judy Airebamen
Alice Cotton
Kaylene Phua
Elodie Murali
Simranjit Mehta
Janine Zylstra
Karen Parry-Billings
Columbus Ife
April Neville
Paul Robinson
Laura Green
Zahra Hanif
Helen Kiconco
Ricardo McEwen
Dominique Arancon
Nicholas Beech
Derya Ovayolu
Christine Hosein
Sylvia Patricia Enes
Qin April Neville
Jane Rowlands
Aashna Samson
Urja Patel
Fahmida Hoque
Hina Pervez
Sofia Nnorom
Moksud Miah
Julian McKee
Mark Clark
Jeannie Eng
Fanta Bojang
Claire Levermore
Anant Patel
Sara Lock
Rajesh Banka
Angshu Bhowmik
Ugo Ekeowa
Zaheer Mangera
William M Ricketts
Neal Navani
Terry O'Shaughnessy
Charlotte Cash
Magali Taylor
Samanjit Hare
Tunku Aziz
Stephen Ellis
Anthony Edey
Graham Robinson
Alberto Villanueva
Hasti Robbie
Elena Stefan
Charlie Sayer
Nick Screaton
Navinah Nundlall
Lyndsey Gallagher
Andrew Crossingham
Thea Buchan
Tanita Limani
Kate Gowers
Kate Davies
John McCabe
Joseph Jacob
Karen Sennett
Tania Anastasiadis
Andrew Perugia
James Rusius
Geoff Bellingan
Maureen Browne
Eleanor Hellier
Catherine Nestor

Funding

Barts Charity G-001522Barts Charity MGU0461Cancer Research UK EDDCPGM\100002CRUK City of London CenterCRUK Lung Cancer CenterCRUK Population Research Fellowship C50664/A24460Garfield Weston TrustMedical Research Council MR/W025051/1Medical Research Council Clinical Academic Research Partnership MR/T02481X/1NIHR Biomedical Research CenterRosetrees TrustRoy Castle Lung Cancer FoundationUniversity College London Hospitals Charitable Foundation
6 · The paper itself

Abstract

introductionIntegrating effective smoking cessation strategies for individuals undergoing lung cancer screening stands to significantly increase the impact of lung screening programmes. We assessed the impact of low-dose computed tomography (LDCT) findings on smoking cessation among high-risk adults who currently smoked. AIMS AND

methods13 035 individuals, aged 55-77 years, attended a lung health check appointment, as part of a prospective observational cohort study (the SUMMIT Study), prior to undergoing a baseline LDCT scan. Logistic regressions examined the likelihood of smoking cessation at a 1-year follow-up appointment and its association with LDCT findings.

results12.6% (n = 647/5135) of individuals self-reported smoking cessation at 1-year follow-up. Higher odds of quitting were found in those receiving indeterminate pulmonary nodule findings requiring a 3-month interval LDCT (aOR = 1.27; 1.01, 1.61), those with urgent findings requiring referral to secondary care (aOR = 1.55; 1.05, 2.32), and those with a possible new chronic obstructive pulmonary disease diagnosis (aOR = 1.60; 1.23, 2.06), compared to those receiving no actionable LDCT findings. Older age, Asian ethnic background, current high smoking intensity, motivation and number of quit attempts, and low nicotine dependence were associated with increased odds of quitting.

conclusionsIndividuals currently smoking, at high lung cancer risk, participating in LDCT screening, and receiving incidental findings requiring a 1-year interval LDCT or primary care follow-up might therefore need additional behavioral support to quit. Tailored communication strategies depending on the severity of the LDCT findings, including additional behavioral support for those with less clinical concerning or negative findings, could increase quit rates and reduce smoking-related morbidity. IMPLICATIONS: This study reports high odds of self-reported complete smoking cessation in adults who currently smoked after receiving their LDCT findings. Though the impact of specific types of LDCT findings on smoking cessation was positive for high lung cancer risk individuals, reception of incidental findings could potentially be perceived as less severe to encourage individuals who currently smoked to quit. Clearly communicating the severity of LDCT findings along with the delivery of behavioral smoking cessation support targeted to high-risk individuals may increase their chances of complete smoking cessation and reduce lung cancer mortality.

Indexed as

Cigarette SmokingEarly Detection of CancerLung NeoplasmsSmoking CessationTomography, X-Ray ComputedAgedFemaleHumansMaleMiddle AgedProspective Studies

Identifiers

PMID40298454
PMCPMC12280174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.